Filing Flows › Comparisons › HUMA vs PLUR
Humacyte vs Pluri: HUMA and PLUR compared
Humacyte is the larger company: $406K of revenue in its latest quarter (Q2 2026) against $335K for Pluri (Q4 FY26). Humacyte is growing faster (+35% against -16% a year earlier).
Where the money goes: HUMA and PLUR
Humacyte (HUMA) · Q2 2026
Humacyte, Q2 2026: revenue $406K (+35% year over year), net loss $36.8M, operating cash flow −$22.1M. The chart follows the revenue to costs, profit and cash.
Pluri (PLUR) · Q4 FY26
Pluri, Q4 FY26: revenue $335K (-16% year over year), net loss $6.2M, operating cash flow −$4.4M. The chart follows the revenue to costs, profit and cash.
| Humacyte (HUMA) | Pluri (PLUR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 FY26 |
| Revenue | $406K | $335K |
| Revenue growth, Y/Y | +35% | -16% |
| Operating margin | n/m | n/m |
| Net earnings | −$36.8M | −$6.2M |
| Operating cash flow | −$22.1M | −$4.4M |
Questions
Which is bigger, Humacyte or Pluri?
Humacyte is the larger company: $406K of revenue in its latest quarter (Q2 2026) against $335K for Pluri (Q4 FY26).
Is Humacyte or Pluri growing faster?
Humacyte is growing faster (+35% against -16% a year earlier).
More: Humacyte earnings · how Humacyte makes money · Pluri earnings · how Pluri makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-K filed Sep 10, 2026). Fiscal quarters can end on different dates. Not investment advice.